TAK-418 is a selective, orally active LSD1 (KDM1A) enzyme inhibitor with an IC50 of 2.9 nM. TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models[1][2].
Molecular Weight:
356.91
Purity:
99.81
CAS Number:
[1818252-53-7]
Formula:
C17H25ClN2O2S
Target:
Histone Demethylase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted